A-1210477, a selective MCL-1 inhibitor, overcomes ABT-737 resistance in AML

Wang, Q; Hao, SG

Hao, SG (reprint author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Hematol, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.

ONCOLOGY LETTERS, 2019; 18 (5): 5481

Abstract

Acute myeloid leukemia (AML) is one of the most common hematological malignancies. It is difficult to treat since it easily develops resistance to the......

Full Text Link